(Q34786075)

4 August 2017

title

Tumor marker usage and medical care costs among older early-stage breast cancer survivors (English)

1 reference

4 August 2017

9

David L Veenstra

1 reference

4 August 2017

Scott D Ramsey

1

1 reference

4 August 2017

N Lynn Henry

2

1 reference

4 August 2017

Julie R Gralow

3

1 reference

4 August 2017

Dana K Mirick

4

1 reference

4 August 2017

William Barlow

5

1 reference

4 August 2017

Ruth Etzioni

6

1 reference

4 August 2017

David Mummy

7

1 reference

4 August 2017

Rahber Thariani

8

1 reference

4 August 2017

language of work or name

English

0 references

publication date

20 October 2014

1 reference

Journal of Clinical Oncology

4 August 2017

published in

1 reference

4 August 2017

volume

33

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

149-155

1 reference

Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Physicians' beliefs about breast cancer surveillance testing are consistent with test overuse

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Development of a comorbidity index using physician claims data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

The GIVIO trial on the impact of follow-up care on survival and quality of life in breast cancer patients. Interdisciplinary Group for Cancer Care Evaluation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Surveillance testing among survivors of early-stage breast cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Economic outcomes of breast cancer survivorship: CALGB study 79804.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Measuring and predicting surgeons' practice styles for breast cancer treatment in older women

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4279234

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators

26 October 2018

1 reference

12 December 2020

Practice patterns and guideline adherence of medical oncologists in managing patients with early breast cancer

1 reference

12 December 2020

C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients

1 reference

12 December 2020

Intensive vs Clinical Follow-up After Treatment of Primary Breast Cancer: 10-Year Update of a Randomized Trial

1 reference

12 December 2020

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value

1 reference

12 December 2020

Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer

1 reference

12 December 2020

Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2014.55.5409

1 reference

4 August 2017

1 reference

4 August 2017

1 reference